Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV – Get Free Report) saw a significant growth in short interest in July. As of July 15th, there was short interest totalling 300 shares, a growth of 50.0% from the June 30th total of 200 shares. Based on an average daily trading volume, of 1,900 shares, the days-to-cover ratio is currently 0.2 days.
Mosaic ImmunoEngineering Price Performance
Shares of CPMV stock remained flat at $0.60 during trading hours on Friday. The company has a market capitalization of $4.33 million, a P/E ratio of -4.60 and a beta of -0.02. Mosaic ImmunoEngineering has a 12 month low of $0.10 and a 12 month high of $0.87. The company’s 50-day simple moving average is $0.52 and its 200-day simple moving average is $0.50.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last announced its earnings results on Tuesday, May 14th. The company reported ($0.04) earnings per share (EPS) for the quarter.
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
Read More
- Five stocks we like better than Mosaic ImmunoEngineering
- What is the Euro STOXX 50 Index?
- Why Call Options Volume for These 2 Stocks Spiked Together
- Industrial Products Stocks Investing
- MarketBeat Week in Review – 7/22 – 7/26
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
